Sustained Mortality Risk Following COVID-19 Hospitalization

The long-term consequences of severe COVID-19 continue to unfold, with emerging data suggesting the acute phase of the illness may only be the beginning of a prolonged health burden. While much attention has focused on the persistent symptoms of Long COVID, the impact of severe infection on long-term survival remains a critical question. A recent retrospective cohort study from Clalit Health Services in Israel provides compelling evidence that the risk of death remains significantly elevated for years after hospital discharge.

A Persistent Hazard
The study matched 16,445 patients aged 40 and older who survived a COVID-19 hospitalization with an equal number of uninfected controls. Over a follow-up period extending up to 3.5 years, the data revealed a stark contrast in survival.

• All-cause mortality was substantially higher in previously hospitalized patients compared to uninfected controls (4.91 vs 2.63 per 1,000 person-months).
• This translated to an adjusted hazard ratio of 1.69 (95% CI, 1.57-1.83), indicating a 69% increased risk of death.
• The relative mortality risk was most pronounced among younger adults aged 40-64 years, who faced more than a twofold increase in risk (HR 2.31; 95% CI, 1.79-2.98) compared to their matched counterparts.

These findings suggest that the physiological toll of severe COVID-19 extends far beyond the acute illness, potentially driven by ongoing viral persistence, chronic inflammation, and exacerbated underlying conditions.

The Role of Comorbidities and Vaccination
The analysis also highlighted the significant role of pre-existing health conditions in amplifying post-discharge mortality. Comorbidities such as cancer, congestive heart failure, renal disease, and dementia were all strongly associated with an increased risk of death in this population.

Conversely, vaccination demonstrated a protective effect, particularly among middle-aged adults. Receiving two or more doses of a COVID-19 vaccine was associated with a 48% reduction in mortality risk for those aged 40-64 years. While the protective association was weaker and not statistically significant in the older cohort, the overall trend underscores the importance of vaccination in mitigating long-term risks.

Interpreting the Data
It is important to note that while the relative risk of mortality remained elevated throughout the 3.5-year follow-up, the hazard ratio progressively attenuated over time. This decline likely reflects a survival bias, where the remaining cohort is enriched with individuals who had less severe initial organ injury or greater physiological reserve, rather than a complete resolution of the excess risk. The absolute mortality rates remained persistently higher in the COVID-19 survivor group.

Furthermore, the study's reliance on data from the pre-Omicron era and the potential for unrecognized infections during the Omicron wave warrant consideration. However, the robust matching strategy and comprehensive electronic health record data strengthen the validity of the findings.

Clinical Implications
For healthcare providers, these results emphasize the need for vigilant, long-term monitoring of patients who have survived a COVID-19 hospitalization. Systematic screening for cardiovascular complications, management of exacerbated chronic conditions, and continued advocacy for vaccination are essential components of post-acute care.

As the pandemic's legacy continues to shape patient health, recognizing and addressing these sustained mortality risks will be crucial for optimizing long-term outcomes.

Reference: 
Ahmad WA, Wolff-Sagy Y, Battat E, Arbel R, Lavie G. Mortality following recovery from COVID-19 hospitalization: A long-term cohort study. Int J Infect Dis. 2026;163:108223. doi:10.1016/j.ijid.2025.108223